Free Trial

Bain Capital Specialty Finance (BCSF) Financials

Bain Capital Specialty Finance logo
$12.34 -0.56 (-4.31%)
Closing price 06/15/2026 03:59 PM Eastern
Extended Trading
$12.38 +0.03 (+0.25%)
As of 07:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Bain Capital Specialty Finance

Annual Income Statements for Bain Capital Specialty Finance

This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-47 120 105 -23 119 -13
Consolidated Net Income / (Loss)
-47 105 120 -23 132 -13
Net Income / (Loss) Continuing Operations
-47 105 120 -23 132 -13
Total Pre-Tax Income
-47 105 120 -23 132 -13
Total Revenue
-43 163 184 -12 215 -1.81
Net Interest Income / (Expense)
-63 116 114 -80 148 -81
Total Interest Income
0.00 167 166 0.00 222 0.00
Total Interest Expense
63 51 52 80 75 81
Long-Term Debt Interest Expense
63 51 52 80 75 81
Total Non-Interest Income
21 47 70 68 68 79
Other Service Charges
2.16 6.17 15 11 19 9.88
Net Realized & Unrealized Capital Gains on Investments
18 17 17 57 -2.70 69
Total Non-Interest Expense
4.67 58 65 11 83 11
Other Operating Expenses
4.67 39 45 11 54 11
Basic Earnings per Share
$0.14 $1.86 $1.63 $1.91 $1.85 $1.53
Weighted Average Basic Shares Outstanding
58.67M 64.56M 64.56M 64.56M 64.56M 64.82M
Diluted Earnings per Share
$0.14 $1.86 $1.63 $1.91 $1.85 $1.53
Weighted Average Diluted Shares Outstanding
58.67M 64.56M 64.56M 64.56M 64.56M 64.82M
Weighted Average Basic & Diluted Shares Outstanding
- - 64.56M 64.56M 64.61M 64.87M

Quarterly Income Statements for Bain Capital Specialty Finance

This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-38 -9.91 35 29 33 22 -34 24 19 -21 -13
Consolidated Net Income / (Loss)
-38 -18 39 28 31 34 -34 19 22 -20 -13
Net Income / (Loss) Continuing Operations
-38 -18 39 28 31 34 -34 19 22 -20 -13
Total Pre-Tax Income
-38 -18 39 28 31 34 -34 19 22 -20 -13
Total Revenue
-34 -28 62 49 52 53 -31 37 40 -48 -9.74
Net Interest Income / (Expense)
-21 -77 38 37 37 35 -19 32 34 -128 -20
Total Interest Income
0.00 -58 56 55 55 56 0.00 54 54 -108 0.00
Total Interest Expense
21 19 18 18 18 21 19 22 20 20 20
Long-Term Debt Interest Expense
21 19 18 18 18 21 19 22 20 20 20
Total Non-Interest Income
-14 49 24 12 14 18 -12 5.02 5.88 80 11
Other Service Charges
1.01 2.38 5.26 3.14 5.70 4.50 2.88 4.16 1.61 1.24 1.50
Net Realized & Unrealized Capital Gains on Investments
-15 62 5.17 -5.45 -2.89 0.47 -15 -12 -7.39 103 9.01
Total Non-Interest Expense
3.18 -11 22 22 20 19 3.29 19 18 -28 2.77
Other Operating Expenses
3.18 -6.67 13 14 13 14 3.29 13 13 -18 2.77
Basic Earnings per Share
$0.52 $0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05
Weighted Average Basic Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M
Diluted Earnings per Share
$0.52 $0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05
Weighted Average Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M
Weighted Average Basic & Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.61M 64.87M 64.87M 64.87M 64.87M 64.87M

Annual Cash Flow Statements for Bain Capital Specialty Finance

This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
13 127 -79 -12 -13 -42
Net Cash From Operating Activities
89 266 -317 219 -27 30
Net Cash From Continuing Operating Activities
89 266 -317 219 -27 30
Net Income / (Loss) Continuing Operations
8.28 120 105 123 119 99
Consolidated Net Income / (Loss)
8.28 120 105 123 119 99
Amortization Expense
-3.23 0.06 -1.04 -1.76 -1.13 0.05
Non-Cash Adjustments to Reconcile Net Income
78 167 -393 109 -125 -45
Changes in Operating Assets and Liabilities, net
-22 -21 -28 -12 -21 -24
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-77 -139 238 -231 14 -72
Net Cash From Continuing Financing Activities
-77 -139 238 -231 14 -72
Issuance of Debt
597 1,425 793 348 867 1,306
Issuance of Common Equity
132 - - 0.00 0.00 5.48
Repayment of Debt
-716 -1,476 -467 -480 -738 -1,238
Payment of Dividends
-86 -88 -88 -99 -114 -146
Cash Interest Paid
68 47 43 75 70 77
Cash Income Taxes Paid
0.00 0.24 0.13 0.83 2.25 3.34

Quarterly Cash Flow Statements for Bain Capital Specialty Finance

This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-22 6.57 10 -24 -39 40 -5.29 78 -88 -28 -25
Net Cash From Operating Activities
122 149 -64 192 -136 -20 -7.27 0.65 9.00 27 27
Net Cash From Continuing Operating Activities
122 148 -64 193 -136 -20 -7.27 0.65 9.00 27 27
Net Income / (Loss) Continuing Operations
34 31 35 29 33 22 29 24 19 28 3.39
Consolidated Net Income / (Loss)
34 31 35 29 33 22 29 24 19 28 3.39
Amortization Expense
-0.37 -0.01 -0.58 -0.09 -0.03 -0.43 -0.41 0.05 0.41 -0.01 -0.21
Non-Cash Adjustments to Reconcile Net Income
90 119 -102 174 -161 -34 -49 -6.65 -26 37 32
Changes in Operating Assets and Liabilities, net
-1.09 -2.76 3.49 -11 -7.48 -7.87 14 -16 16 -38 -9.02
Net Cash From Investing Activities
- - 0.00 - - - 0.00 - - - 0.00
Net Cash From Continuing Investing Activities
- - 0.00 - - - 0.00 - - - 0.00
Net Cash From Financing Activities
-145 -142 74 -217 97 60 1.98 78 -97 -55 -51
Net Cash From Continuing Financing Activities
-145 -142 74 -217 97 60 1.98 78 -97 -55 -51
Issuance of Debt
20 20 198 99 268 302 459 300 406 141 643
Issuance of Common Equity
- - 0.00 - - - 5.48 - - - 0.00
Repayment of Debt
-140 -135 -97 -286 -142 -213 -404 -193 -473 -167 -657
Payment of Dividends
-25 -27 -27 -29 -29 -29 -58 -29 -29 -29 -37
Cash Interest Paid
21 20 18 18 16 19 20 18 20 19 20
Cash Income Taxes Paid
0.01 0.00 2.25 - 0.16 -0.16 3.34 - - - 0.00

Annual Balance Sheets for Bain Capital Specialty Finance

This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,571 2,592 2,472 2,632 2,663
Cash and Due from Banks
117 30 43 52 23
Restricted Cash
86 66 63 46 33
Trading Account Securities
5.32 0.06 0.00 2,436 0.00
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00
Deferred Acquisition Cost
2.18 3.74 2.80 - 3.54
Other Assets
77 100 2,351 83 100
Total Liabilities & Shareholders' Equity
2,571 2,592 2,472 2,632 2,663
Total Liabilities
1,471 1,476 1,336 1,492 1,545
Accrued Interest Payable
7.06 12 13 14 12
Long-Term Debt
1,415 1,385 1,256 1,390 1,471
Other Long-Term Liabilities
49 79 48 60 62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,100 1,116 1,136 1,140 1,117
Total Preferred & Common Equity
1,100 1,116 1,136 1,140 1,117
Total Common Equity
1,168 1,116 1,136 1,140 1,117
Common Stock
1,168 1,168 1,168 1,160 1,161
Retained Earnings
- -52 -32 -20 -44

Quarterly Balance Sheets for Bain Capital Specialty Finance

This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
4.53 2,606 2,675 2,566 2,580 2,415 2,544 2,642 2,774 2,716 2,602
Cash and Due from Banks
- 23 88 65 47 18 25 10 28 41 13
Restricted Cash
- 51 36 26 74 67 29 56 137 26 18
Trading Account Securities
- 1.11 0.06 5.85 0.92 0.65 - 1.47 0.00 0.00 2,476
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
4.53 125 161 2,443 2,449 91 77 2,509 105 2,590 78
Total Liabilities & Shareholders' Equity
0.00 2,606 2,675 2,566 2,580 2,415 2,544 2,642 2,774 2,716 2,602
Total Liabilities
0.00 1,485 1,550 1,434 1,438 1,272 1,397 1,498 1,635 1,587 1,508
Accrued Interest Payable
- 14 16 15 13 12 13 12 14 13 11
Other Short-Term Payables
- - - - - - - 0.00 - - 17
Long-Term Debt
- 1,408 1,490 1,370 1,358 1,174 1,301 1,451 1,563 1,496 1,455
Other Long-Term Liabilities
- 63 44 42 49 87 83 25 59 63 6.27
Commitments & Contingencies
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.00 1,168 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094
Total Preferred & Common Equity
0.00 1,121 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094
Total Common Equity
0.00 1,168 1,126 1,133 1,143 1,143 1,147 1,145 1,139 1,129 1,094
Common Stock
- 1,168 1,168 1,168 1,165 1,165 1,165 1,164 1,164 1,164 1,161
Retained Earnings
- - -43 -36 -23 -23 -19 -20 -25 -36 -68

Annual Metrics And Ratios for Bain Capital Specialty Finance

This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 64,868,507.00
DEI Adjusted Shares Outstanding
- - - - - 64,868,507.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.20
Growth Metrics
- - - - - -
Revenue Growth
0.00% 481.63% 13.00% -106.66% 1,854.77% -100.84%
EBITDA Growth
0.00% 563.96% 13.26% -121.30% 617.59% -109.97%
EBIT Growth
0.00% 321.00% 14.31% -119.64% 661.08% -109.92%
NOPAT Growth
0.00% 415.72% 14.31% -113.75% 901.54% -106.94%
Net Income Growth
0.00% 321.00% 14.31% -119.64% 661.08% -109.92%
EPS Growth
0.00% 1,228.57% -12.37% 17.18% -3.14% -17.30%
Operating Cash Flow Growth
0.00% 196.98% -219.31% 169.21% -112.36% 208.95%
Free Cash Flow Firm Growth
0.00% 0.00% 105.52% -30.24% -105.97% -1,117.57%
Invested Capital Growth
0.00% 0.00% -0.53% -4.37% 5.75% 2.30%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -110.47% 60.59% -101.83%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -142.75% 64.46% -132.40%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -138.44% 64.43% -132.22%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -127.93% 64.43% -122.56%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -134.37% 64.43% -132.22%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -7.50% 6.25%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -1.95% 64.08% -119.14% 267.65%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -104.08% 50.81%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -4.41% 3.38% -1.40%
Profitability Metrics
- - - - - -
EBITDA Margin
0.00% 64.28% 64.42% 0.00% 60.79% 0.00%
EBIT Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Profit (Net Income) Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 8.33% 4.77% 0.00% 5.36% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 8.33% 4.77% 0.00% 5.36% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 10.72% 6.03% 0.00% 6.24% 0.00%
Return on Equity (ROE)
0.00% 19.05% 10.81% -2.09% 11.60% -1.16%
Cash Return on Invested Capital (CROIC)
0.00% -191.67% 5.30% 3.79% -0.23% -2.63%
Operating Return on Assets (OROA)
0.00% 4.07% 4.64% 0.00% 5.17% 0.00%
Return on Assets (ROA)
0.00% 4.07% 4.64% 0.00% 5.17% 0.00%
Return on Common Equity (ROCE)
0.00% 20.23% 11.14% -2.09% 11.60% -1.16%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.52% 10.73% -2.07% 11.58% -1.17%
Net Operating Profit after Tax (NOPAT)
-33 105 120 -16 132 -9.17
NOPAT Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.53% 0.00% 0.27%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 35.76% 35.01% 0.00% 38.69% 0.00%
Earnings before Interest and Taxes (EBIT)
-47 105 120 -24 132 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 105 119 -25 131 -13
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.54 0.75 0.97 0.81
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.54 0.75 0.97 0.81
Price to Revenue (P/Rev)
0.00 0.00 3.25 0.00 5.11 0.00
Price to Earnings (P/E)
0.00 0.00 5.68 0.00 9.22 0.00
Dividend Yield
18.31% 12.71% 14.88% 12.15% 8.09% 14.02%
Earnings Yield
0.00% 0.00% 17.62% 0.00% 10.85% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.75 0.84 0.95 0.90
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 10.24 0.00 11.12 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 15.90 0.00 18.29 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 15.76 0.00 18.13 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 15.76 0.00 18.13 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 9.12 0.00 78.49
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 14.19 21.54 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 1.29 1.24 1.11 1.22 1.32
Long-Term Debt to Equity
0.00 1.29 1.24 1.11 1.22 1.32
Financial Leverage
0.00 1.29 1.26 1.17 1.16 1.27
Leverage Ratio
0.00 2.34 2.33 2.25 2.24 2.35
Compound Leverage Factor
0.00 2.34 2.33 2.25 2.24 2.35
Debt to Total Capital
0.00% 56.26% 55.37% 52.50% 54.95% 56.83%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 56.26% 55.37% 52.50% 54.95% 56.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% -2.72% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 46.46% 44.63% 47.50% 45.05% 43.17%
Debt to EBITDA
0.00 13.50 11.67 -49.67 10.62 -112.76
Net Debt to EBITDA
0.00 11.56 10.86 -45.47 9.88 -108.48
Long-Term Debt to EBITDA
0.00 13.50 11.67 -49.67 10.62 -112.76
Debt to NOPAT
0.00 13.51 11.57 -76.26 10.53 -160.48
Net Debt to NOPAT
0.00 11.56 10.76 -69.82 9.80 -154.39
Long-Term Debt to NOPAT
0.00 13.51 11.57 -76.26 10.53 -160.48
Noncontrolling Interest Sharing Ratio
0.00% -6.22% -3.09% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,410 133 93 -5.54 -67
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -46.94 2.54 1.16 -0.07 -0.84
Operating Cash Flow to Interest Expense
1.41 5.17 -6.06 2.74 -0.36 0.37
Operating Cash Flow Less CapEx to Interest Expense
1.41 5.17 -6.06 2.74 -0.36 0.37
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.06 0.07 0.00 0.08 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 2,515 2,502 2,392 2,530 2,588
Invested Capital Turnover
0.00 0.13 0.07 0.00 0.09 0.00
Increase / (Decrease) in Invested Capital
0.00 2,515 -13 -109 138 58
Enterprise Value (EV)
0.00 0.00 1,888 2,000 2,394 2,317
Market Capitalization
0.00 0.00 599 850 1,101 902
Book Value per Share
$0.00 $18.10 $17.29 $17.60 $17.65 $17.23
Tangible Book Value per Share
$0.00 $18.10 $17.29 $17.60 $17.65 $17.23
Total Capital
0.00 2,515 2,502 2,392 2,530 2,588
Total Debt
0.00 1,415 1,385 1,256 1,390 1,471
Total Long-Term Debt
0.00 1,415 1,385 1,256 1,390 1,471
Net Debt
0.00 1,211 1,289 1,150 1,293 1,415
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
14 0.00 0.00 7.06 0.00 3.93
Net Nonoperating Obligations (NNO)
0.00 1,415 1,385 1,256 1,390 1,471
Total Depreciation and Amortization (D&A)
25 0.06 -1.04 -1.76 -1.13 0.05
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.63 $1.91 $1.85 $1.53
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 64.56M 64.56M 64.56M 64.82M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.63 $1.91 $1.85 $1.53
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 64.56M 64.56M 64.56M 64.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 64.56M 64.56M 64.61M 64.87M
Normalized Net Operating Profit after Tax (NOPAT)
-33 73 84 -16 92 -9.17
Normalized NOPAT Margin
0.00% 44.97% 45.49% 0.00% 42.92% 0.00%
Pre Tax Income Margin
0.00% 64.24% 64.99% 0.00% 61.31% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-0.75 2.04 2.29 -0.29 1.77 -0.16
NOPAT to Interest Expense
-0.52 2.04 2.29 -0.21 1.77 -0.11
EBIT Less CapEx to Interest Expense
-0.75 2.04 2.29 -0.29 1.77 -0.16
NOPAT Less CapEx to Interest Expense
-0.52 2.04 2.29 -0.21 1.77 -0.11
Payout Ratios
- - - - - -
Dividend Payout Ratio
-181.94% 83.81% 73.32% -422.60% 86.57% -1,113.70%
Augmented Payout Ratio
-181.94% 83.81% 73.32% -422.60% 86.57% -1,113.70%

Quarterly Metrics And Ratios for Bain Capital Specialty Finance

This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 64,868,507.00 64,868,507.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 64,868,507.00 64,868,507.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.30 -0.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-282.04% -127.99% 2,261.24% -7.60% 250.07% 287.08% -149.90% -23.74% -23.35% -190.72% 68.32%
EBITDA Growth
-343.27% -126.38% 725.68% -24.26% 182.02% 291.05% -189.79% -31.26% -28.47% -158.12% 63.07%
EBIT Growth
-340.19% -126.25% 843.10% -25.00% 182.91% 293.55% -187.43% -31.67% -29.85% -157.36% 63.24%
NOPAT Growth
-268.14% -119.01% 1,161.57% -25.00% 218.44% 376.50% -161.20% -31.67% -29.85% -140.15% 63.24%
Net Income Growth
-340.19% -123.70% 843.10% -25.00% 182.91% 293.55% -187.43% -31.67% -29.85% -157.36% 63.24%
EPS Growth
0.00% 0.00% 22.22% 0.00% -1.92% -30.61% -20.00% -17.78% -43.14% 26.47% -88.64%
Operating Cash Flow Growth
222.69% 135.81% -48.26% 2,293.15% -211.07% -113.44% 88.59% -99.66% 106.62% 235.86% 466.43%
Free Cash Flow Firm Growth
-22,845.60% 0.00% 102.69% 112.66% 103.43% -206.68% -275.51% -212.17% -279.78% 30.39% 132.44%
Invested Capital Growth
55,210.25% -4.37% -1.15% -11.43% -2.22% 5.75% 3.82% 16.63% 7.26% 2.30% -1.83%
Revenue Q/Q Growth
-164.54% 17.63% 317.76% -20.17% 4.81% 2.68% -158.09% 221.88% 5.44% -221.62% 79.73%
EBITDA Q/Q Growth
-204.12% 53.50% 318.71% -28.48% 12.76% 8.32% -202.79% 154.68% 17.50% -188.11% 35.09%
EBIT Q/Q Growth
-201.74% 53.05% 322.04% -29.29% 12.48% 9.61% -200.30% 155.18% 15.63% -189.74% 36.12%
NOPAT Q/Q Growth
-171.22% 53.05% 417.20% -29.29% 12.48% 9.61% -170.21% 178.82% 15.63% -162.82% 36.12%
Net Income Q/Q Growth
-201.74% 53.05% 322.04% -29.29% 12.48% 9.61% -200.30% 155.18% 15.63% -189.74% 36.12%
EPS Q/Q Growth
15.56% -5.77% 12.24% -18.18% 13.33% -33.33% 29.41% -15.91% -21.62% 48.28% -88.37%
Operating Cash Flow Q/Q Growth
1,494.01% 21.56% -142.83% 402.14% -170.60% 85.29% 63.63% 108.89% 1,292.57% 201.81% -1.90%
Free Cash Flow Firm Q/Q Growth
2.09% 103.84% -29.74% 379.39% -73.45% -219.30% -15.58% -206.34% 57.44% 53.83% 153.82%
Invested Capital Q/Q Growth
-4.31% -4.41% 4.50% -7.34% 5.64% 3.38% 2.60% 4.08% -2.84% -1.40% -1.55%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
0.00% 0.00% 62.56% 56.05% 60.30% 63.61% 0.00% 50.50% 56.27% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 1.32% 1.10% 3.27% 5.64% 0.00% 2.23% 2.16% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 1.32% 1.10% 3.27% 5.64% 0.00% 2.23% 2.16% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 1.55% 1.29% 3.83% 6.55% 0.00% 2.68% 2.66% 0.00% 0.00%
Return on Equity (ROE)
0.00% -2.09% 2.87% 2.39% 7.10% 12.19% 0.00% 4.91% 4.82% -1.16% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 3.79% 1.98% 12.59% 5.49% -0.23% -1.45% -13.36% -5.41% -2.63% 2.17%
Operating Return on Assets (OROA)
0.00% 0.00% 1.28% 1.06% 3.17% 5.43% 0.00% 2.16% 2.08% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 1.28% 1.06% 3.17% 5.43% 0.00% 2.16% 2.08% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% -2.09% 2.87% 2.39% 7.10% 12.19% 0.00% 4.91% 4.82% -1.16% 0.00%
Return on Equity Simple (ROE_SIMPLE)
6.04% 0.00% 1.83% 1.02% 7.00% 0.00% 5.13% 4.38% 3.60% 0.00% 0.77%
Net Operating Profit after Tax (NOPAT)
-26 -12 39 28 31 34 -24 19 22 -14 -8.76
NOPAT Margin
0.00% 0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
1.64% 0.40% 0.00% 0.00% 0.00% 0.00% 0.73% 0.00% 0.00% 0.41% 0.26%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 36.50% 43.76% 39.65% 35.58% 0.00% 49.64% 44.77% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-38 -18 39 28 31 34 -34 19 22 -20 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-38 -18 39 28 31 34 -35 19 22 -20 -13
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.74 0.75 0.80 0.85 0.89 0.97 0.94 0.86 0.82 0.81 0.74
Price to Tangible Book Value (P/TBV)
0.74 0.75 0.80 0.85 0.89 0.97 0.94 0.86 0.82 0.81 0.74
Price to Revenue (P/Rev)
7.17 0.00 17.43 20.20 7.58 5.11 8.73 8.77 9.32 0.00 41.91
Price to Earnings (P/E)
17.26 0.00 54.06 58.06 11.63 9.22 21.40 21.80 30.45 0.00 95.41
Dividend Yield
11.83% 12.15% 8.87% 8.76% 8.57% 8.09% 11.02% 14.96% 15.79% 14.02% 15.48%
Earnings Yield
5.80% 0.00% 1.85% 1.72% 8.59% 10.85% 4.67% 4.59% 3.28% 0.00% 1.05%
Enterprise Value to Invested Capital (EV/IC)
0.85 0.84 0.86 0.89 0.92 0.95 0.95 0.88 0.90 0.90 0.87
Enterprise Value to Revenue (EV/Rev)
18.09 0.00 41.14 42.80 16.88 11.12 20.00 21.33 23.72 0.00 116.10
Enterprise Value to EBITDA (EV/EBITDA)
35.83 0.00 110.55 194.62 28.43 18.29 42.59 48.33 58.46 0.00 256.82
Enterprise Value to EBIT (EV/EBIT)
34.63 0.00 102.93 177.10 28.18 18.13 41.89 47.54 57.92 0.00 264.32
Enterprise Value to NOPAT (EV/NOPAT)
35.94 0.00 102.93 177.10 28.18 18.13 41.89 47.54 57.92 0.00 264.32
Enterprise Value to Operating Cash Flow (EV/OCF)
15.86 9.12 10.82 5.16 15.98 0.00 83.83 0.00 0.00 78.49 35.13
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 21.54 43.07 6.64 16.65 0.00 0.00 0.00 0.00 0.00 39.85
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.21 1.11 1.19 1.03 1.13 1.22 1.27 1.37 1.33 1.32 1.33
Long-Term Debt to Equity
1.21 1.11 1.19 1.03 1.13 1.22 1.27 1.37 1.33 1.32 1.33
Financial Leverage
1.21 1.17 1.18 1.17 1.17 1.16 1.23 1.20 1.23 1.27 1.30
Leverage Ratio
2.27 2.25 2.24 2.24 2.24 2.24 2.28 2.27 2.31 2.35 2.34
Compound Leverage Factor
2.27 2.25 2.24 2.24 2.24 2.24 2.28 2.27 2.31 2.35 2.34
Debt to Total Capital
54.75% 52.50% 54.30% 50.68% 53.15% 54.95% 55.91% 57.84% 57.01% 56.83% 57.09%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
54.75% 52.50% 54.30% 50.68% 53.15% 54.95% 55.91% 57.84% 57.01% 56.83% 57.09%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
45.25% 47.50% 45.70% 49.32% 46.85% 45.05% 44.09% 42.16% 42.99% 43.17% 42.91%
Debt to EBITDA
23.16 -49.67 69.90 110.84 16.34 10.62 25.14 31.82 37.17 -112.76 167.65
Net Debt to EBITDA
21.62 -45.47 63.70 102.78 15.66 9.88 24.00 28.46 35.50 -108.48 164.12
Long-Term Debt to EBITDA
23.16 -49.67 69.90 110.84 16.34 10.62 25.14 31.82 37.17 -112.76 167.65
Debt to NOPAT
23.24 -76.26 65.07 100.86 16.20 10.53 24.73 31.30 36.83 -160.48 172.54
Net Debt to NOPAT
21.69 -69.82 59.31 93.52 15.52 9.80 23.61 28.00 35.18 -154.39 168.91
Long-Term Debt to NOPAT
23.24 -76.26 65.07 100.86 16.20 10.53 24.73 31.30 36.83 -160.48 172.54
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,525 97 68 327 87 -103 -120 -366 -156 -72 39
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-121.52 5.04 3.77 18.52 4.79 -4.95 -6.32 -16.82 -7.68 -3.67 1.91
Operating Cash Flow to Interest Expense
5.89 7.73 -3.53 10.91 -7.50 -0.96 -0.38 0.03 0.44 1.39 1.32
Operating Cash Flow Less CapEx to Interest Expense
5.89 7.73 -3.53 10.91 -7.50 -0.96 -0.38 0.03 0.44 1.39 1.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.09 0.00 0.02 0.02 0.05 0.08 0.05 0.04 0.04 0.00 0.01
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,503 2,392 2,500 2,316 2,447 2,530 2,596 2,702 2,625 2,588 2,548
Invested Capital Turnover
0.09 0.00 0.02 0.02 0.05 0.09 0.05 0.04 0.04 0.00 0.01
Increase / (Decrease) in Invested Capital
2,498 -109 -29 -299 -56 138 96 385 178 58 -47
Enterprise Value (EV)
2,119 2,000 2,147 2,061 2,263 2,394 2,458 2,373 2,354 2,317 2,228
Market Capitalization
840 850 910 973 1,017 1,101 1,073 976 924 902 804
Book Value per Share
$17.54 $17.60 $17.70 $17.70 $17.76 $17.65 $17.71 $17.56 $17.40 $17.23 $16.86
Tangible Book Value per Share
$17.54 $17.60 $17.70 $17.70 $17.76 $17.65 $17.71 $17.56 $17.40 $17.23 $16.86
Total Capital
2,503 2,392 2,500 2,316 2,447 2,530 2,596 2,702 2,625 2,588 2,548
Total Debt
1,370 1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455
Total Long-Term Debt
1,370 1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455
Net Debt
1,279 1,150 1,237 1,089 1,246 1,293 1,385 1,398 1,429 1,415 1,424
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
11 5.29 0.00 0.00 0.00 0.00 10 0.00 0.00 5.88 3.75
Net Nonoperating Obligations (NNO)
1,370 1,256 1,358 1,174 1,301 1,390 1,451 1,563 1,496 1,471 1,455
Total Depreciation and Amortization (D&A)
-0.37 -0.01 -0.58 -0.09 -0.03 -0.43 -0.41 0.05 0.41 -0.01 -0.21
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 $0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05
Adjusted Weighted Average Basic Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M
Adjusted Diluted Earnings per Share
$0.00 $0.49 $0.55 $0.45 $0.51 $0.34 $0.44 $0.37 $0.29 $0.43 $0.05
Adjusted Weighted Average Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.56M 64.68M 64.87M 64.87M 64.82M 64.87M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.47 $0.45 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.56M 64.56M 64.56M 64.56M 64.56M 64.61M 64.87M 64.87M 64.87M 64.87M 64.87M
Normalized Net Operating Profit after Tax (NOPAT)
-26 -12 27 19 22 24 -24 13 15 -14 -8.76
Normalized NOPAT Margin
0.00% 0.00% 44.45% 39.37% 42.25% 45.10% 0.00% 35.25% 38.66% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 63.50% 56.24% 60.35% 64.42% 0.00% 50.36% 55.23% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1.81 -0.92 2.17 1.57 1.72 1.63 -1.81 0.87 1.07 -1.00 -0.62
NOPAT to Interest Expense
-1.26 -0.64 2.17 1.57 1.72 1.63 -1.27 0.87 1.07 -0.70 -0.43
EBIT Less CapEx to Interest Expense
-1.81 -0.92 2.17 1.57 1.72 1.63 -1.81 0.87 1.07 -1.00 -0.62
NOPAT Less CapEx to Interest Expense
-1.26 -0.64 2.17 1.57 1.72 1.63 -1.27 0.87 1.07 -0.70 -0.43
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
137.70% -422.60% 495.16% 926.36% 139.93% 86.57% 247.82% 291.53% 358.52% -1,113.70% 1,477.26%
Augmented Payout Ratio
137.70% -422.60% 495.16% 926.36% 139.93% 86.57% 247.82% 291.53% 358.52% -1,113.70% 1,477.26%

Financials Breakdown Chart

Key Financial Trends

Bain Capital Specialty Finance (NYSE: BCSF) showed a sharp quarter-over-quarter turnaround in Q1 2026, but the longer trend still looks mixed. The company moved from a loss in Q4 2025 to a profit in Q1 2026 on a reported basis, while keeping leverage and shareholder equity relatively stable. However, revenue quality remains uneven, and the balance sheet is still heavily dependent on debt financing and investment gains rather than steady operating income.

  • Q1 2026 returned to profitability on a reported basis, with net income of $3.4 million after a $19.6 million loss in Q4 2025.
  • Cash from operations was strong in Q1 2026 at $26.6 million, showing the business can still generate cash even when accounting earnings are volatile.
  • Total equity rose to $1.09 billion at the end of Q1 2026, up from $1.08 billion roughly a year earlier, supporting a solid equity base.
  • Book equity held up well despite volatile earnings, with total common equity of $1.09 billion versus liabilities of $1.51 billion.
  • Shares outstanding were essentially flat year over year, indicating little dilution in the recent period.
  • The company continues to use significant debt financing, with long-term debt of $1.45 billion in Q1 2026.
  • Non-interest income remains an important swing factor, as realized and unrealized investment gains can materially change quarterly results.
  • Q1 2026 total revenue was still negative at -$9.7 million, showing interest expense continues to outweigh core interest income in the reported structure.
  • Earnings have been volatile over the last several quarters, swinging from strong profits in late 2024 to weaker results and even losses in 2025.
  • Dividend payments and debt repayments continue to consume cash, which limits the amount of internally generated capital that can be retained.

Looking at the last four years, BCSF’s pattern is clear: the company has not produced consistent quarterly operating earnings, but it has repeatedly generated enough cash to support dividends and manage debt. In 2024, results were generally stronger, with several profitable quarters and healthy operating cash flow. In 2025, profitability became more erratic, including a weak Q1 and a loss in Q4. Q1 2026 improved again, but not enough to say the trend has fully stabilized.

Balance sheet trends are also worth watching. Total assets ended Q1 2026 at $2.60 billion, down from $2.72 billion in Q3 2025, while long-term debt declined from $1.50 billion to $1.45 billion over the same period. That suggests some balance-sheet discipline. Still, the business remains highly levered, and because earnings are sensitive to market gains and funding costs, future results could remain lumpy.

Bottom line: BCSF appears to be in decent financial shape from a liquidity and equity standpoint, but its earnings profile is inconsistent. For retail investors, the key question is whether the company can convert its cash-generation ability into more stable, repeatable profits.

06/16/26 07:24 AM ETAI Generated. May Contain Errors.

Bain Capital Specialty Finance Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bain Capital Specialty Finance's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Bain Capital Specialty Finance's net income appears to be on an upward trend, with a most recent value of -$13.09 million in 2025, falling from -$47.41 million in 2020. The previous period was $132.01 million in 2024. Check out Bain Capital Specialty Finance's forecast to explore projected trends and price targets.

Over the last 5 years, Bain Capital Specialty Finance's total revenue changed from -$42.73 million in 2020 to -$1.81 million in 2025, a change of -95.8%.

Bain Capital Specialty Finance's total liabilities were at $1.55 billion at the end of 2025, a 3.5% increase from 2024, and a 5.0% increase since 2021.

In the past 4 years, Bain Capital Specialty Finance's cash and equivalents has ranged from $23.09 million in 2025 to $117.42 million in 2021, and is currently $23.09 million as of their latest financial filing in 2025.

Over the last 5 years, Bain Capital Specialty Finance's book value per share changed from 0.00 in 2020 to 17.23 in 2025, a change of 1,722.6%.



Financial statements for NYSE:BCSF last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners